Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
02/24/2004 | US6696084 Spray drying process and compositions of fenofibrate |
02/24/2004 | US6696083 Administering vitamin b1, thiamine, niacinamide, folic acid, riboflavin, pantothenic acid, vitamin b, pyridoxine, and/or vitamin b12 to human during sleep; oxidation resistance |
02/24/2004 | US6696082 Enhanced liposomal thioretinaco ozonide compositions and liposomal carrier |
02/24/2004 | US6696081 Lipids where the glycerol backbone is replaced with a carbohydrate; conjugates; drug delivery |
02/24/2004 | US6696080 Vortexing lipid film with water; homogenizing suspension; repeatedly freeze-thawing in liquid nitrogen; encapsulation; giant multivesicular liposomes |
02/24/2004 | US6696079 Delivery and activation through liposome incorporation of diaminocyclohexane platinum(II) complexes |
02/24/2004 | US6696078 Applying patch to skin comprising mixture of penetration enhancer, macrolide antibiotic, and tetracycline antibiotic as analgesic for snake and insect bites |
02/24/2004 | US6696075 Heating below glass transition temperature; exposure to pressure; cooling; biodegradable polyanhydrides, polyesters, polyamides, and polyaromatics; encapsulated time-release agents |
02/24/2004 | US6696066 Opioid agonist/antagonist combinations |
02/24/2004 | US6696056 Pharmaceutical compositions of erythropoietin |
02/24/2004 | US6696055 Disinfectant substance comprising an iodine impregnated resin for use in sterilizing a fluid such as water or air |
02/24/2004 | US6696042 Inhalation aerosol comprising tiotropium salt and propellant gas; respiratory system disorders |
02/24/2004 | US6696041 Treatment of colds, flu like infections and other general nasal based infections with a solution containing iodine and other broad spectrum microbicides and a method for its use |
02/24/2004 | US6696038 Cationic lipopolymer as biocompatible gene delivery agent |
02/24/2004 | US6695238 Device for pulverizing desiccated bulk product in a freeze-drying apparatus for foodstuffs, medicaments, and so forth |
02/24/2004 | CA2352802C Preparation of multiwall polymeric microcapsules from hydrophilic polymers |
02/24/2004 | CA2315067C Aqueous insecticidal pour-on formulation |
02/24/2004 | CA2125401C Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of making and using them |
02/24/2004 | CA2078860C Film-forming product intended for coating solid forms |
02/23/2004 | CA2399532A1 Controlled release formulation of divalproex sodium |
02/23/2004 | CA2399528A1 Controlled release formulation of divalproex sodium |
02/19/2004 | WO2004014903A1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
02/19/2004 | WO2004014849A2 Isosorbide mononitrate compositions and methods of their use |
02/19/2004 | WO2004014639A2 An apparatus for bench scale tablet-making |
02/19/2004 | WO2004014451A1 Active agent delivery systems, medical devices, and methods |
02/19/2004 | WO2004014447A1 Active agent delivery system including a poly(ethylene-co-(meth)acrylate), medical device, and method |
02/19/2004 | WO2004014446A1 Embolization |
02/19/2004 | WO2004014431A1 A parenteral dosage form of selective cox-2 inhibitors |
02/19/2004 | WO2004014411A1 Nasal peptide pharmaceutical formulation |
02/19/2004 | WO2004014408A1 Intravaginal washing agent |
02/19/2004 | WO2004014402A1 Activated carbon for preventing pregnancy and sexually transmitted disease |
02/19/2004 | WO2004014399A1 Process for preparing a sterile high molecular weight hyaluronic acid formulation |
02/19/2004 | WO2004014395A1 Female hormone-containing patch |
02/19/2004 | WO2004014373A1 Pharmaceutical compositions comprising fk506 derivatives and the ir use for the treatment of allergic diseases |
02/19/2004 | WO2004014360A2 Pharmaceutical compositions for the treatment of urinary incontinence |
02/19/2004 | WO2004014356A1 Solid compositions comprising gabapentin having improved stability |
02/19/2004 | WO2004014353A1 Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine |
02/19/2004 | WO2004014347A1 Particles which are surface coated with hyaluronan or one of the derivatives thereof and the use of same as biological vectors for active substances |
02/19/2004 | WO2004014346A1 Palatable controlled-release formulation for companion animals |
02/19/2004 | WO2004014345A1 Pharmaceutical preparation containing a benzimidazole compound mixed with microcrystalline cellulose and a method for its preparation |
02/19/2004 | WO2004014344A1 Film coating for tablets and caplets |
02/19/2004 | WO2004014343A1 Storage stable tablets of fosinopril sodium |
02/19/2004 | WO2004014342A1 Pharmaceutical compositions of semi-ordered drugs and polymers |
02/19/2004 | WO2004014341A1 Oral injectable pharmaceutical composition comprising florfenicol as an active ingredient |
02/19/2004 | WO2004014340A1 Injectable composition comprising florfenicol as an active ingredient |
02/19/2004 | WO2004014339A1 Injectable composition comprising ceftiofur sodium as an active ingredient |
02/19/2004 | WO2004014338A1 Composition and method for rectal delivery of a lincosamide antibacterial drug |
02/19/2004 | WO2004014337A2 A process for the preparation of dispersible tablet of cephalexin |
02/19/2004 | WO2004014336A2 Opioid-receptor antagonists in transdermal systems having buprenorphine |
02/19/2004 | WO2004014335A2 Dual-spike release formulation for oral drug delivery |
02/19/2004 | WO2004014322A2 Immunomodulatory compositions, methods of making, and methods of use thereof |
02/19/2004 | WO2004014318A2 Levothyroxine compositions and methods |
02/19/2004 | WO2004014304A2 Electrospun amorphous pharmaceutical compositions |
02/19/2004 | WO2004014286A1 A capsule filling machine |
02/19/2004 | WO2004014254A1 Implantable artifical pancreas |
02/19/2004 | WO2004014156A2 A chemical carrier based on a beta-limit dextrin |
02/19/2004 | WO2004014152A1 Multi-phase delivery system comprising a semi-solid matrix phase |
02/19/2004 | WO2004014143A1 Compositions and process for delivering an additive |
02/19/2004 | WO2004006953A3 Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells |
02/19/2004 | WO2004006886A3 Injectable depot formulation comprising crystals of iloperidone |
02/19/2004 | WO2003105826A3 "soluble stable pharmaceutical composition for the administration of hiv protease inhibitors and a process for the preparation of concentrated pharmaceutical compositions for the administration of hiv protease inhibitors." |
02/19/2004 | WO2003105664A3 Optical sampling interface system for in vivo measurement of tissue |
02/19/2004 | WO2003103576A3 Reconstitutable compositions of biodegradable block copolymers |
02/19/2004 | WO2003092596A3 TREATING ECZEMA WITH A COMBINATION OF ISOTONIC SALINE OCEANè AND MAST CELL STABILIZERS |
02/19/2004 | WO2003089423A3 Novel flavanoids and chalcones as chemotherapeutic, chemopreventive, and antiangiogenic agents |
02/19/2004 | WO2003071930A3 Systems and methods for remotely controlling medication infusion and analyte monitoring |
02/19/2004 | WO2003059391A3 Viscoelastics for ocular surgery |
02/19/2004 | WO2003049593A3 Prevention of flap necrosis in plastic surgery |
02/19/2004 | WO2003045411A3 Ginger extract preparation |
02/19/2004 | WO2003032907A3 High-concentration protein formulations and method of manufacture |
02/19/2004 | WO2003024383B1 Methods and apparatus for improved administration of analgesics |
02/19/2004 | WO2002087512A3 Once-a-day oxycodone formulations |
02/19/2004 | WO2002072067A3 Pharmaceutical aerosol formulation |
02/19/2004 | WO2002015887A8 Consumable container |
02/19/2004 | WO2001020981A3 Anti-infective compositions for treating disordered tissue such as cold sores |
02/19/2004 | WO2000018447A3 Multiplex drug delivery system suitable for oral administration |
02/19/2004 | US20040034338 Drug delivery devices and methods |
02/19/2004 | US20040034337 Time-release agents; biocompatible stents |
02/19/2004 | US20040034336 Charged liposomes/micelles with encapsulted medical compounds |
02/19/2004 | US20040034332 Implantable drug delivery device |
02/19/2004 | US20040034242 Compounds containing a specific branched chain end terminal group, which is isopropyl, sec.-butyl, or tert.-butyl; a polar leading group, and long chain aliphatic, non-cyclic, saturated or nonsaturated linking groups |
02/19/2004 | US20040034231 Amidinophenyl-4-aminoacetic acid derivative is useful for treating diseases such as thrombosis, apoplexy, cardiac infarction, inflammation and arteriosclerosis, which are associated with coagulation factors xa, IXa and thrombin |
02/19/2004 | US20040034108 Pharmaceutical formulation |
02/19/2004 | US20040034102 Oral pediatric trimethobenzamide formulations and methods |
02/19/2004 | US20040034099 4-(bis(2-chloroethyl)amino)-L-phenylalanine derivatives and microcrystalline cellulose; antineoplastic agents |
02/19/2004 | US20040034087 Comprises phosphodiesterase inhibitor and beta-2-adrenoceptor agonist; for treatment of respiratory tract disorders |
02/19/2004 | US20040034068 New formulation and use thereof |
02/19/2004 | US20040034062 Novel aqueous anti-inflammatory pharmaceutical formulation |
02/19/2004 | US20040034059 A dosage concentration about 0.4 to 75 mg/mL of fentanyl in water, for the pain treatment |
02/19/2004 | US20040034058 Inhalation asthma treatment with an aqueous solution of (2S)-3-(4-(((4-(aminocarbonyl)-1-piperidinyl)carbonyl)oxy) phenyl)-2-(((2S)-4-methyl-2-((2-(2-methylphenoxy)acetyl)amino) pentanoyl)amino) propanoic acid or a salt |
02/19/2004 | US20040034053 Veterinary treatment of ophthalmic disease in animals using toptical tacrolimus |
02/19/2004 | US20040034042 Formulations containing a xanthine, e.g., caffeine, a buffer and a known preservative, e.g., sorbic acid, ethylenediamine-tetraacetic acid (EDTA) and salts; synergistic; storage stability; solutions and ointments of eyes; contact lenses |
02/19/2004 | US20040034039 An oval tablet comprising a drug, e.g., an antigonadotrophin, a slightly water-soluble, water-repellant, cellulose-type disintegrant, a binder and a stearate lubricant; improved granulability; storage stability; drug delivery; oval tablets |
02/19/2004 | US20040034030 A unit dosage form as adjuvant to biguanide (metformin) or sulfonylurea (glyburide) therapy for supporting mitochondrial metabolism containing carnitine, ascorbic acid, choline, taurine, foic acid and magnesium; side-effect reduction |
02/19/2004 | US20040034029 Composition and method for altering levels of or sensitivity to adenosine with a dehydroepiandrosterone |
02/19/2004 | US20040034021 Intravenous rifalazil formulation and methods of use thereof |
02/19/2004 | US20040034016 Diuretic or sulphonylurea for use in antiviral treatment |
02/19/2004 | US20040034006 Combining blood product with (a porphyrin compound) a photosensitiser, and activating the photosensitiser |
02/19/2004 | US20040033999 Testosterone derivative |
02/19/2004 | US20040033985 Composition for regulating animal growth, method of manufacture and use thereof |